Back to results
US 2026/0218203 A1Published application
CXCL8 Binding Nucleic Acids
AssigneeAPTARION biotech AG
InventorsKai Hohlig, Axel Vater, Werner Purschke, Dirk Zboralski, Christian Maasch
Life of this patent
Estimating the term…
Abstract
The present invention is related to an L-nucleic acid molecule capable of binding to human CXCL8, wherein the L-nucleic acid molecule comprises a central stretch of nucleotides, wherein the central stretch of nucleotides comprises a nucleotide sequence of 5′-GG A AGU ACGUGGA AAGCCRA(Xu)RAGUGUGUCCCG-3′ [SEQ. ID. NO: 27], wherein Xu is U or absent.
Claims17
1-103. (canceled)
An L-nucleic acid molecule that binds human CXCL8, wherein the L-nucleic acid molecule comprises a central stretch of nucleotides, wherein the central stretch of nucleotides comprises a nucleotide sequence of
- [SEQ. ID. NO:
- 27]
- 5′-GGAAGUACGUGGAAAGCCRA(XU)RAGUGUGUCCCG-3′,
- wherein XU is U or absent.
1 more element
Dependencies are inferred from the claim text.